5 Einträge gefunden

1. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

   1. Melling, Nathaniel
   2. Thomsen, Erik
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE
2. Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

   1. Burdelski, Christoph
   2. Barreau, Ysé
   3. Simon, Ronald
   4. Hube-Magg, Claudia
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2015 - Forschungsinformationssystem des UKE
3. VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

   1. Tsourlakis, Maria Christina
   2. Khosrawi, Puya
   3. Weigand, Philipp
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
4. Marked heterogeneity of ERG expression in large primary prostate cancers.

   1. Minner, Sarah
   2. Gärtner, Michael
   3. Freudenthaler, Fabian
   4. Bauer, Melanie
   5. Kluth, Martina
   6. Salomon, Georg
   7. Heinzer, Hans

   2013 - Forschungsinformationssystem des UKE
5. Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.

   1. Isbarn, Hendrik
   2. Wanner, Manuela
   3. Salomon, Georg
   4. Steuber, Thomas
   5. Schlomm, Thorsten
   6. Köllermann, Jens
   7. Sauter, Guido

   2009 - Forschungsinformationssystem des UKE